nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—Balance disorder—Vandetanib—thyroid cancer	0.0219	0.0742	CcSEcCtD
Dalfampridine—KCNA7—thyroid gland—thyroid cancer	0.0183	0.0335	CbGeAlD
Dalfampridine—KCNS1—saliva-secreting gland—thyroid cancer	0.0169	0.0307	CbGeAlD
Dalfampridine—KCNH4—head—thyroid cancer	0.0163	0.0297	CbGeAlD
Dalfampridine—KCNB2—head—thyroid cancer	0.0163	0.0297	CbGeAlD
Dalfampridine—KCNG4—head—thyroid cancer	0.0163	0.0297	CbGeAlD
Dalfampridine—KCNH5—head—thyroid cancer	0.0149	0.0272	CbGeAlD
Dalfampridine—KCNS2—head—thyroid cancer	0.0138	0.0252	CbGeAlD
Dalfampridine—KCNA6—head—thyroid cancer	0.0138	0.0252	CbGeAlD
Dalfampridine—KCNF1—saliva-secreting gland—thyroid cancer	0.0138	0.0252	CbGeAlD
Dalfampridine—KCNV1—head—thyroid cancer	0.013	0.0237	CbGeAlD
Dalfampridine—KCNV2—head—thyroid cancer	0.0123	0.0225	CbGeAlD
Dalfampridine—KCNG3—head—thyroid cancer	0.0118	0.0215	CbGeAlD
Dalfampridine—KCNC2—head—thyroid cancer	0.0118	0.0215	CbGeAlD
Dalfampridine—KCNH1—head—thyroid cancer	0.0118	0.0215	CbGeAlD
Dalfampridine—KCNQ1—neck—thyroid cancer	0.0114	0.0208	CbGeAlD
Dalfampridine—KCNC3—thyroid gland—thyroid cancer	0.0111	0.0203	CbGeAlD
Dalfampridine—KCNH3—head—thyroid cancer	0.0105	0.0191	CbGeAlD
Dalfampridine—KCNG1—head—thyroid cancer	0.0105	0.0191	CbGeAlD
Dalfampridine—KCNH8—head—thyroid cancer	0.0102	0.0185	CbGeAlD
Dalfampridine—KCNB1—head—thyroid cancer	0.0102	0.0185	CbGeAlD
Dalfampridine—KCNC3—head—thyroid cancer	0.00986	0.018	CbGeAlD
Dalfampridine—KCNC4—thyroid gland—thyroid cancer	0.00984	0.0179	CbGeAlD
Dalfampridine—KCNA4—head—thyroid cancer	0.00959	0.0175	CbGeAlD
Dalfampridine—KCNA3—head—thyroid cancer	0.00959	0.0175	CbGeAlD
Dalfampridine—KCNA5—trachea—thyroid cancer	0.00952	0.0174	CbGeAlD
Dalfampridine—KCNS3—trachea—thyroid cancer	0.00933	0.017	CbGeAlD
Dalfampridine—KCNQ5—thyroid gland—thyroid cancer	0.00919	0.0168	CbGeAlD
Dalfampridine—KCNA2—head—thyroid cancer	0.00912	0.0166	CbGeAlD
Dalfampridine—KCNS1—head—thyroid cancer	0.00912	0.0166	CbGeAlD
Dalfampridine—KCNQ1—saliva-secreting gland—thyroid cancer	0.00889	0.0162	CbGeAlD
Dalfampridine—KCNC4—head—thyroid cancer	0.00873	0.0159	CbGeAlD
Dalfampridine—KCND1—head—thyroid cancer	0.00873	0.0159	CbGeAlD
Dalfampridine—KCNH7—head—thyroid cancer	0.00838	0.0153	CbGeAlD
Dalfampridine—KCNC1—head—thyroid cancer	0.00838	0.0153	CbGeAlD
Dalfampridine—KCNQ4—head—thyroid cancer	0.00838	0.0153	CbGeAlD
Dalfampridine—KCNQ5—head—thyroid cancer	0.00816	0.0149	CbGeAlD
Dalfampridine—Nasopharyngitis—Vandetanib—thyroid cancer	0.00778	0.0263	CcSEcCtD
Dalfampridine—KCNA5—thyroid gland—thyroid cancer	0.00753	0.0137	CbGeAlD
Dalfampridine—KCNF1—head—thyroid cancer	0.00747	0.0136	CbGeAlD
Dalfampridine—KCNS3—thyroid gland—thyroid cancer	0.00738	0.0135	CbGeAlD
Dalfampridine—KCNC2—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—PRKAR1A—thyroid cancer	0.00686	0.0439	CbGpPWpGaD
Dalfampridine—KCNS3—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—PRKAR1A—thyroid cancer	0.00686	0.0439	CbGpPWpGaD
Dalfampridine—KCNG2—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—PRKAR1A—thyroid cancer	0.00686	0.0439	CbGpPWpGaD
Dalfampridine—KCNA3—lymph node—thyroid cancer	0.00672	0.0123	CbGeAlD
Dalfampridine—Infestation—Vandetanib—thyroid cancer	0.00671	0.0227	CcSEcCtD
Dalfampridine—Infestation NOS—Vandetanib—thyroid cancer	0.00671	0.0227	CcSEcCtD
Dalfampridine—KCNA5—head—thyroid cancer	0.00668	0.0122	CbGeAlD
Dalfampridine—KCNS3—head—thyroid cancer	0.00654	0.0119	CbGeAlD
Dalfampridine—KCNQ3—head—thyroid cancer	0.00654	0.0119	CbGeAlD
Dalfampridine—Urinary tract infection—Vandetanib—thyroid cancer	0.00652	0.0221	CcSEcCtD
Dalfampridine—KCNB1—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—PRKAR1A—thyroid cancer	0.0065	0.0416	CbGpPWpGaD
Dalfampridine—KCNA2—lymph node—thyroid cancer	0.00639	0.0117	CbGeAlD
Dalfampridine—KCNC4—lymph node—thyroid cancer	0.00611	0.0111	CbGeAlD
Dalfampridine—KCNQ2—head—thyroid cancer	0.00602	0.011	CbGeAlD
Dalfampridine—KCNH6—head—thyroid cancer	0.00597	0.0109	CbGeAlD
Dalfampridine—KCNQ5—lymph node—thyroid cancer	0.00571	0.0104	CbGeAlD
Dalfampridine—KCND2—head—thyroid cancer	0.0057	0.0104	CbGeAlD
Dalfampridine—KCNA1—thyroid gland—thyroid cancer	0.00563	0.0103	CbGeAlD
Dalfampridine—KCND3—thyroid gland—thyroid cancer	0.00561	0.0102	CbGeAlD
Dalfampridine—Angiopathy—Vandetanib—thyroid cancer	0.00546	0.0185	CcSEcCtD
Dalfampridine—KCNQ1—thyroid gland—thyroid cancer	0.00543	0.0099	CbGeAlD
Dalfampridine—Mediastinal disorder—Vandetanib—thyroid cancer	0.00543	0.0184	CcSEcCtD
Dalfampridine—Mental disorder—Vandetanib—thyroid cancer	0.00527	0.0178	CcSEcCtD
Dalfampridine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00525	0.0178	CcSEcCtD
Dalfampridine—KCNA1—head—thyroid cancer	0.005	0.00912	CbGeAlD
Dalfampridine—KCND3—head—thyroid cancer	0.00497	0.00907	CbGeAlD
Dalfampridine—Tremor—Vandetanib—thyroid cancer	0.00491	0.0166	CcSEcCtD
Dalfampridine—KCNQ1—head—thyroid cancer	0.00482	0.00878	CbGeAlD
Dalfampridine—KCNA5—lymph node—thyroid cancer	0.00468	0.00854	CbGeAlD
Dalfampridine—KCNS3—lymph node—thyroid cancer	0.00458	0.00836	CbGeAlD
Dalfampridine—Convulsion—Vandetanib—thyroid cancer	0.00454	0.0154	CcSEcCtD
Dalfampridine—Infestation NOS—Sorafenib—thyroid cancer	0.00452	0.0153	CcSEcCtD
Dalfampridine—Infestation—Sorafenib—thyroid cancer	0.00452	0.0153	CcSEcCtD
Dalfampridine—Chest pain—Vandetanib—thyroid cancer	0.00446	0.0151	CcSEcCtD
Dalfampridine—Anxiety—Vandetanib—thyroid cancer	0.00445	0.015	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00443	0.015	CcSEcCtD
Dalfampridine—Infection—Vandetanib—thyroid cancer	0.00425	0.0144	CcSEcCtD
Dalfampridine—KCNS3—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00422	0.027	CbGpPWpGaD
Dalfampridine—KCNC2—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00422	0.027	CbGpPWpGaD
Dalfampridine—KCNG2—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00422	0.027	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Vandetanib—thyroid cancer	0.00419	0.0142	CcSEcCtD
Dalfampridine—Skin disorder—Vandetanib—thyroid cancer	0.00415	0.0141	CcSEcCtD
Dalfampridine—KCNB1—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00401	0.0256	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Sorafenib—thyroid cancer	0.00399	0.0135	CcSEcCtD
Dalfampridine—Insomnia—Vandetanib—thyroid cancer	0.00387	0.0131	CcSEcCtD
Dalfampridine—Paraesthesia—Vandetanib—thyroid cancer	0.00384	0.013	CcSEcCtD
Dalfampridine—Dyspnoea—Vandetanib—thyroid cancer	0.00381	0.0129	CcSEcCtD
Dalfampridine—Dyspepsia—Vandetanib—thyroid cancer	0.00377	0.0127	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00369	0.0125	CcSEcCtD
Dalfampridine—Angiopathy—Sorafenib—thyroid cancer	0.00368	0.0125	CcSEcCtD
Dalfampridine—Immune system disorder—Sorafenib—thyroid cancer	0.00367	0.0124	CcSEcCtD
Dalfampridine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00366	0.0124	CcSEcCtD
Dalfampridine—Constipation—Vandetanib—thyroid cancer	0.00366	0.0124	CcSEcCtD
Dalfampridine—Mental disorder—Sorafenib—thyroid cancer	0.00356	0.012	CcSEcCtD
Dalfampridine—KCND3—lymph node—thyroid cancer	0.00348	0.00635	CbGeAlD
Dalfampridine—KCNQ1—lymph node—thyroid cancer	0.00337	0.00615	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00337	0.0216	CbGpPWpGaD
Dalfampridine—KCNC2—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00332	0.0213	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00332	0.0213	CbGpPWpGaD
Dalfampridine—KCNS3—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00332	0.0213	CbGpPWpGaD
Dalfampridine—Angioedema—Sorafenib—thyroid cancer	0.00323	0.0109	CcSEcCtD
Dalfampridine—KCNB1—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00315	0.0201	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00313	0.02	CbGpPWpGaD
Dalfampridine—Asthenia—Vandetanib—thyroid cancer	0.00307	0.0104	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00299	0.0101	CcSEcCtD
Dalfampridine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00289	0.00976	CcSEcCtD
Dalfampridine—Infection—Sorafenib—thyroid cancer	0.00287	0.0097	CcSEcCtD
Dalfampridine—Nervous system disorder—Sorafenib—thyroid cancer	0.00283	0.00957	CcSEcCtD
Dalfampridine—Dizziness—Vandetanib—thyroid cancer	0.00283	0.00957	CcSEcCtD
Dalfampridine—Skin disorder—Sorafenib—thyroid cancer	0.0028	0.00948	CcSEcCtD
Dalfampridine—Vomiting—Vandetanib—thyroid cancer	0.00272	0.0092	CcSEcCtD
Dalfampridine—Rash—Vandetanib—thyroid cancer	0.0027	0.00913	CcSEcCtD
Dalfampridine—Dermatitis—Vandetanib—thyroid cancer	0.00269	0.00912	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00268	0.0172	CbGpPWpGaD
Dalfampridine—Headache—Vandetanib—thyroid cancer	0.00268	0.00907	CcSEcCtD
Dalfampridine—Dyspnoea—Sorafenib—thyroid cancer	0.00257	0.0087	CcSEcCtD
Dalfampridine—Nausea—Vandetanib—thyroid cancer	0.00254	0.0086	CcSEcCtD
Dalfampridine—Dyspepsia—Sorafenib—thyroid cancer	0.00254	0.00859	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00249	0.00843	CcSEcCtD
Dalfampridine—Constipation—Sorafenib—thyroid cancer	0.00247	0.00835	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.00236	0.0151	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00234	0.015	CbGpPWpGaD
Dalfampridine—Urticaria—Sorafenib—thyroid cancer	0.00229	0.00776	CcSEcCtD
Dalfampridine—Hypersensitivity—Sorafenib—thyroid cancer	0.00213	0.00719	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00208	0.0133	CbGpPWpGaD
Dalfampridine—Asthenia—Sorafenib—thyroid cancer	0.00207	0.007	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00194	0.00656	CcSEcCtD
Dalfampridine—Dizziness—Sorafenib—thyroid cancer	0.00191	0.00646	CcSEcCtD
Dalfampridine—KCNH2—head—thyroid cancer	0.00184	0.00335	CbGeAlD
Dalfampridine—Vomiting—Sorafenib—thyroid cancer	0.00183	0.00621	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—EPO—thyroid cancer	0.00183	0.0117	CbGpPWpGaD
Dalfampridine—Rash—Sorafenib—thyroid cancer	0.00182	0.00616	CcSEcCtD
Dalfampridine—Dermatitis—Sorafenib—thyroid cancer	0.00182	0.00615	CcSEcCtD
Dalfampridine—Headache—Sorafenib—thyroid cancer	0.00181	0.00612	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.0018	0.00607	CcSEcCtD
Dalfampridine—Nausea—Sorafenib—thyroid cancer	0.00171	0.0058	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—thyroid cancer	0.00167	0.00566	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—thyroid cancer	0.00167	0.00566	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00165	0.0105	CbGpPWpGaD
Dalfampridine—Urinary tract infection—Epirubicin—thyroid cancer	0.00163	0.0055	CcSEcCtD
Dalfampridine—CYP2E1—thyroid gland—thyroid cancer	0.00159	0.00291	CbGeAlD
Dalfampridine—Infestation—Doxorubicin—thyroid cancer	0.00155	0.00523	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—thyroid cancer	0.00155	0.00523	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—thyroid cancer	0.0015	0.00509	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00147	0.00499	CcSEcCtD
Dalfampridine—CYP2E1—head—thyroid cancer	0.00141	0.00258	CbGeAlD
Dalfampridine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00136	0.00462	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—thyroid cancer	0.00136	0.00461	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—thyroid cancer	0.00136	0.00459	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00135	0.00458	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—thyroid cancer	0.00131	0.00445	CcSEcCtD
Dalfampridine—KCNH2—lymph node—thyroid cancer	0.00129	0.00235	CbGeAlD
Dalfampridine—Back pain—Epirubicin—thyroid cancer	0.00126	0.00428	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—thyroid cancer	0.00126	0.00426	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—thyroid cancer	0.00125	0.00424	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00125	0.00423	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00125	0.00798	CbGpPWpGaD
Dalfampridine—Mental disorder—Doxorubicin—thyroid cancer	0.00122	0.00412	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—thyroid cancer	0.00117	0.00396	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00116	0.00742	CbGpPWpGaD
Dalfampridine—Convulsion—Epirubicin—thyroid cancer	0.00113	0.00383	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—thyroid cancer	0.00111	0.00376	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—thyroid cancer	0.00111	0.00375	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.0011	0.00374	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—thyroid cancer	0.00108	0.00364	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00107	0.00361	CcSEcCtD
Dalfampridine—Infection—Epirubicin—thyroid cancer	0.00106	0.00358	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—thyroid cancer	0.00105	0.00354	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—thyroid cancer	0.00105	0.00354	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—MINPP1—thyroid cancer	0.00104	0.00667	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MINPP1—thyroid cancer	0.00104	0.00667	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MINPP1—thyroid cancer	0.00104	0.00667	CbGpPWpGaD
Dalfampridine—Skin disorder—Epirubicin—thyroid cancer	0.00104	0.0035	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—thyroid cancer	0.00103	0.00348	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—thyroid cancer	0.00103	0.00347	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00102	0.00346	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—thyroid cancer	0.000996	0.00337	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—thyroid cancer	0.000995	0.00337	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—MINPP1—thyroid cancer	0.000989	0.00633	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000989	0.00632	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000987	0.00334	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—thyroid cancer	0.00098	0.00332	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000968	0.00327	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—thyroid cancer	0.000964	0.00326	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—thyroid cancer	0.000958	0.00324	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—thyroid cancer	0.000958	0.00324	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—thyroid cancer	0.000951	0.00322	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—thyroid cancer	0.000939	0.00318	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—thyroid cancer	0.000922	0.00312	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000921	0.00311	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—thyroid cancer	0.000912	0.00309	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—thyroid cancer	0.000892	0.00302	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—NDUFA13—thyroid cancer	0.000887	0.00568	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NDUFA13—thyroid cancer	0.000887	0.00568	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NDUFA13—thyroid cancer	0.000887	0.00568	CbGpPWpGaD
Dalfampridine—Paraesthesia—Doxorubicin—thyroid cancer	0.000886	0.003	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—thyroid cancer	0.00088	0.00298	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—thyroid cancer	0.000879	0.00297	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—thyroid cancer	0.000869	0.00294	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000852	0.00288	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—thyroid cancer	0.000847	0.00287	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—thyroid cancer	0.000844	0.00285	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—NDUFA13—thyroid cancer	0.000841	0.00538	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CHST14—thyroid cancer	0.000834	0.00534	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CHST14—thyroid cancer	0.000834	0.00534	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CHST14—thyroid cancer	0.000834	0.00534	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—BRAF—thyroid cancer	0.000832	0.00532	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000813	0.00275	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—CHST14—thyroid cancer	0.000791	0.00506	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—thyroid cancer	0.000786	0.00266	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—thyroid cancer	0.000784	0.00265	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000771	0.00493	CbGpPWpGaD
Dalfampridine—Asthenia—Epirubicin—thyroid cancer	0.000765	0.00259	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—BRAF—thyroid cancer	0.000742	0.00475	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000727	0.00246	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—thyroid cancer	0.000708	0.0024	CcSEcCtD
Dalfampridine—KCNQ5—Neuronal System—BRAF—thyroid cancer	0.000708	0.00453	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—BRAF—thyroid cancer	0.000708	0.00453	CbGpPWpGaD
Dalfampridine—Dizziness—Epirubicin—thyroid cancer	0.000705	0.00239	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.000699	0.00447	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PPARG—thyroid cancer	0.000686	0.00439	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—thyroid cancer	0.000678	0.00229	CcSEcCtD
Dalfampridine—Rash—Epirubicin—thyroid cancer	0.000672	0.00227	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—HPGD—thyroid cancer	0.000672	0.0043	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HPGD—thyroid cancer	0.000672	0.0043	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HPGD—thyroid cancer	0.000672	0.0043	CbGpPWpGaD
Dalfampridine—Dermatitis—Epirubicin—thyroid cancer	0.000672	0.00227	CcSEcCtD
Dalfampridine—Headache—Epirubicin—thyroid cancer	0.000668	0.00226	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—thyroid cancer	0.000652	0.00221	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—HPGD—thyroid cancer	0.000637	0.00408	CbGpPWpGaD
Dalfampridine—Nausea—Epirubicin—thyroid cancer	0.000633	0.00214	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—thyroid cancer	0.000627	0.00212	CcSEcCtD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000625	0.004	CbGpPWpGaD
Dalfampridine—Rash—Doxorubicin—thyroid cancer	0.000622	0.0021	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—thyroid cancer	0.000622	0.0021	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—thyroid cancer	0.000618	0.00209	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000609	0.0039	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PPARG—thyroid cancer	0.0006	0.00384	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—CDK1—thyroid cancer	0.000594	0.0038	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—CDK1—thyroid cancer	0.000594	0.0038	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—BRAF—thyroid cancer	0.000593	0.00379	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—BRAF—thyroid cancer	0.000593	0.00379	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—BRAF—thyroid cancer	0.000593	0.00379	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—thyroid cancer	0.000586	0.00198	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—HRAS—thyroid cancer	0.000579	0.0037	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—BRAF—thyroid cancer	0.000577	0.00369	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—BRAF—thyroid cancer	0.000562	0.0036	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—BRAF—thyroid cancer	0.000514	0.00329	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—BRAF—thyroid cancer	0.000514	0.00329	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—thyroid cancer	0.000511	0.00327	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—BRAF—thyroid cancer	0.000504	0.00323	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000479	0.00307	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000477	0.00305	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—thyroid cancer	0.000471	0.00301	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—BRAF—thyroid cancer	0.000456	0.00292	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—BRAF—thyroid cancer	0.000449	0.00288	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDK1—thyroid cancer	0.000424	0.00271	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDK1—thyroid cancer	0.000424	0.00271	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—thyroid cancer	0.000412	0.00263	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RXRA—thyroid cancer	0.000393	0.00252	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RXRA—thyroid cancer	0.000393	0.00252	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000388	0.00248	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TPR—thyroid cancer	0.000386	0.00247	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TPR—thyroid cancer	0.000386	0.00247	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TPR—thyroid cancer	0.000386	0.00247	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—thyroid cancer	0.000383	0.00245	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BRAF—thyroid cancer	0.000382	0.00244	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BRAF—thyroid cancer	0.000382	0.00244	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PRKAR1A—thyroid cancer	0.00038	0.00243	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PRKAR1A—thyroid cancer	0.00038	0.00243	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PRKAR1A—thyroid cancer	0.00038	0.00243	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TPR—thyroid cancer	0.000366	0.00234	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000366	0.00234	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PRKAR1A—thyroid cancer	0.00036	0.0023	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—thyroid cancer	0.000341	0.00218	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—thyroid cancer	0.000325	0.00208	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—thyroid cancer	0.000325	0.00208	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—thyroid cancer	0.000321	0.00206	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC5A5—thyroid cancer	0.000289	0.00185	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC5A5—thyroid cancer	0.000289	0.00185	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC5A5—thyroid cancer	0.000289	0.00185	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—thyroid cancer	0.000281	0.0018	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A5—thyroid cancer	0.000274	0.00175	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—thyroid cancer	0.000273	0.00174	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—thyroid cancer	0.000273	0.00174	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—thyroid cancer	0.000273	0.00174	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—thyroid cancer	0.000265	0.0017	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—thyroid cancer	0.000258	0.00165	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—thyroid cancer	0.000248	0.00159	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—thyroid cancer	0.000248	0.00159	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—RXRA—thyroid cancer	0.000243	0.00155	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—RXRA—thyroid cancer	0.000243	0.00155	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—RXRA—thyroid cancer	0.000243	0.00155	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—thyroid cancer	0.000236	0.00151	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—thyroid cancer	0.000236	0.00151	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—thyroid cancer	0.000232	0.00148	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RXRA—thyroid cancer	0.00023	0.00147	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—thyroid cancer	0.000213	0.00136	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—thyroid cancer	0.000213	0.00136	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—thyroid cancer	0.00021	0.00134	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—thyroid cancer	0.000207	0.00132	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000206	0.00132	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—thyroid cancer	0.00019	0.00122	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—thyroid cancer	0.000183	0.00117	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—thyroid cancer	0.000183	0.00117	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—thyroid cancer	0.000176	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—thyroid cancer	0.000176	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—thyroid cancer	0.000156	0.000997	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—thyroid cancer	0.000156	0.000997	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—thyroid cancer	0.000153	0.000981	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—thyroid cancer	0.000153	0.000981	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—thyroid cancer	0.000153	0.000981	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—thyroid cancer	0.000152	0.000973	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—thyroid cancer	0.000152	0.000973	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.000152	0.00097	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—thyroid cancer	0.000145	0.00093	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—thyroid cancer	0.000131	0.000837	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—thyroid cancer	0.000131	0.000837	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFA13—thyroid cancer	0.000129	0.000825	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CHST14—thyroid cancer	0.000121	0.000775	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—thyroid cancer	0.000121	0.000772	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—thyroid cancer	0.000121	0.000772	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—thyroid cancer	0.000121	0.000772	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—thyroid cancer	0.000114	0.000732	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—thyroid cancer	0.000111	0.000712	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—thyroid cancer	0.000111	0.000712	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—thyroid cancer	0.000105	0.000673	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—thyroid cancer	0.000105	0.000673	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—thyroid cancer	0.000105	0.000673	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—thyroid cancer	9.97e-05	0.000638	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—thyroid cancer	9.82e-05	0.000628	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—thyroid cancer	9.82e-05	0.000628	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGD—thyroid cancer	9.77e-05	0.000625	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—thyroid cancer	8.75e-05	0.00056	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—thyroid cancer	6.06e-05	0.000388	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—thyroid cancer	6.06e-05	0.000388	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—thyroid cancer	6.06e-05	0.000388	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—thyroid cancer	5.75e-05	0.000368	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TPR—thyroid cancer	5.61e-05	0.000359	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	5.52e-05	0.000353	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	4.2e-05	0.000269	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RXRA—thyroid cancer	3.53e-05	0.000226	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—thyroid cancer	2.23e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.75e-05	0.000112	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—thyroid cancer	1.53e-05	9.78e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—thyroid cancer	8.81e-06	5.64e-05	CbGpPWpGaD
